Foresite Capital Management IV, LLC Diversified Active

Name: Foresite Capital Management IV, LLC Q1 2019 13F Filing | 13F Explorer
Creator: Foresite Capital Management IV, LLC
Published: 2019-05-14

Location: West Hollywood, CA

CIK: 0001704132 · Show all filings

Period: Q1 2019 (← Previous) (Next →)

Filing Date: May 14, 2019

Total Value: $278M (100.0% shares, 0.0% debt)

Holdings (16)

INSM Insmed Incorporated 16.0%

Value $44.59M Shares 1,533,883 Est. Cost $26.83 Unrealized -3.4%

— CymaBay Therapeutics, Inc. 12.6%

Value $34.94M Shares 2,631,258 Est. Cost $8.89 Unrealized —

ASND Ascendis Pharma A/S 10.4%

Value $28.89M Shares 245,424 Est. Cost $40.06 Unrealized —

— Biohaven Pharmaceutical Holding Company Ltd. 9.6%

Value $26.69M Shares 518,560 Est. Cost $26.07 Unrealized —

— OptiNose, Inc. 9.0%

Value $25M Shares 2,427,403 Est. Cost $15.31 Unrealized —

— Immunomedics, Inc. 8.0%

Value $22.32M Shares 1,161,965 Est. Cost $17.13 Unrealized —

— Myokardia, Inc. 7.2%

Value $20.02M Shares 384,993 Est. Cost $45.40 Unrealized —

REPL Replimune Group, Inc. 6.7%

Value $18.71M Shares 1,229,656 Est. Cost $17.53 Unrealized -28.9%

CYTK Cytokinetics Incorporated 5.0%

Value $13.94M Shares 1,723,170 Est. Cost $7.35 Unrealized +0.0%

RYTM Rhythm Pharmaceuticals, Inc. 4.0%

Value $11.1M Shares 405,026 Est. Cost $27.11 Unrealized +6.0%

ALEC Alector, Inc. 3.8%

Value $10.68M Shares 1,203,462 Est. Cost $18.92 Unrealized 0.0%

— Aerie Pharmaceuticals, Inc. 3.6%

Value $10.06M Shares 211,823 Est. Cost $36.10 Unrealized —

SIBN SI-BONE, Inc. 1.4%

Value $3.874M Shares 205,621 Est. Cost $18.92 Unrealized +2.3%

VYGR Voyager Therapeutics, Inc. 1.2%

Value $3.403M Shares 177,804 Est. Cost $19.14 Unrealized —

ABUS Arbutus Biopharma Corporation 1.0%

Value $2.88M Shares 804,446 Est. Cost $5.62 Unrealized -31.6%

— Kiniksa Pharmaceuticals, Ltd. 0.4%

Value $1.154M Shares 63,922 Est. Cost $17.35 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
INSM	Insmed Incorporated	1,533,883	$44.59M	16.0%	$26.83	-3.4%	COM	457669307
—	CymaBay Therapeutics, Inc.	2,631,258	$34.94M	12.6%	$8.89	—	COM	23257D103
ASND	Ascendis Pharma A/S	245,424	$28.89M	10.4%	$40.06	—	SPONSORED ADR	04351P101
—	Biohaven Pharmaceutical Holding Company Ltd.	518,560	$26.69M	9.6%	$26.07	—	COM	G11196105
—	OptiNose, Inc.	2,427,403	$25M	9.0%	$15.31	—	COM	68404V100
—	Immunomedics, Inc.	1,161,965	$22.32M	8.0%	$17.13	—	COM	452907108
—	Myokardia, Inc.	384,993	$20.02M	7.2%	$45.40	—	COM	62857M105
REPL	Replimune Group, Inc.	1,229,656	$18.71M	6.7%	$17.53	-28.9%	COM	76029N106
CYTK	Cytokinetics Incorporated	1,723,170	$13.94M	5.0%	$7.35	+0.0%	COM NEW	23282W605
RYTM	Rhythm Pharmaceuticals, Inc.	405,026	$11.1M	4.0%	$27.11	+6.0%	COM	76243J105
ALEC	Alector, Inc.	1,203,462	$10.68M	3.8%	$18.92	0.0%	COM	014442107
—	Aerie Pharmaceuticals, Inc.	211,823	$10.06M	3.6%	$36.10	—	COM	00771V108
SIBN	SI-BONE, Inc.	205,621	$3.874M	1.4%	$18.92	+2.3%	COM	825704109
VYGR	Voyager Therapeutics, Inc.	177,804	$3.403M	1.2%	$19.14	—	COM	92915B106
ABUS	Arbutus Biopharma Corporation	804,446	$2.88M	1.0%	$5.62	-31.6%	COM	03879J100
—	Kiniksa Pharmaceuticals, Ltd.	63,922	$1.154M	0.4%	$17.35	—	Class A Common	G5269C101